RYBOX Mutual Fund

RYBOX Mutual Fund

NAV$74.98
See how much of RYBOX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$16M
Expense Ratio
1.63%
Dividend Yield (Current)
-
Holdings
69
Inception Date
Sep 1, 2004
Fund Family
Rydex Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+26.04%
1 Year+45.73%
3 Year+31.62%
5 Year+12.28%
10 Year+12.77%

Asset Allocation

Stocks: 99.37%
Other: 0.63%
See how much of RYBOX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
ABBVAbbvie Inc.8.47%
AMGNAmgen Inc.5.58%
GILDGilead Sciences4.81%
VRTXNvaesrtex Pharmaceuticals Inc4.31%
REGNRegeneron Pharmaceuticals, Inc.3.73%
Top 10 Concentration: 38.68%Report Date: Jul 31, 2026
Download all 69 holdings for RYBOX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$15.77
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

RYBOX Mutual Fund Overview

RYBOX Mutual Fund (Rydex Biotechnology Fund Class A) is managed by Rydex Funds with $16.3M in net assets. RYBOX expense ratio is 1.63%, holding 69 positions across sectors including Health Care. Inception date: 2004-09-01.

RYBOX performance shows a YTD return of 26.04%. The 1-year return is 45.73% and the 5-year return is 12.28%.

RYBOX top holdings include Abbvie Inc. (8.5%), Amgen Inc. (5.6%), Gilead Sciences (4.8%), Nvaesrtex Pharmaceuticals Inc (4.3%), Regeneron Pharmaceuticals, Inc. (3.7%). Go to all RYBOX holdings, RYBOX sectors, or RYBOX dividends.

RYBOX can be compared against other funds. Use RYBOX overlap to find shared positions, or RYBOX vs another fund for a side-by-side view. RYBOX alternatives are available via the screener, along with tax-loss harvesting opportunities.